baber/WOPTO huggingface dataset:
Patent JP-H0417703-B2 (JP)
IPC: B01L3/14
Filed: 1984-01-13
Abstract: Apparatus for collecting test samples including a support plate and a plurality of integrally connected vessels, which are supported by the support plate. The support plate includes an upper surface having a predetermined number of recesses aligned in at least one row. The internal dimensional configuration of one of the recesses in each of the rows is different from the configuration characteristic of the remainder of the recesses in the row. The recess with the different internal dimensional configuration is asymmetrically disposed along each of the rows. The vessels from at least one line and the number of vessels in each line is equivalent to the predetermined number of recesses in one of the rows. The base of the vessels has a shape corresponding to the internal dimensional configuration of an opposing recess, such that the base of one of the vessels in each line is different from the remainder of vessels in the same line. Each line of vessels is capable of being positioned within a corresponding one of the rows in only one sequence.
Patent JP-2858771-B2 (JP)
IPC: C12Q1/6827
Filed: 1989-01-13
Granted: 1999-02-17
Abstract: Methods, apparatus and compositions are presented for ligating ligands together which bind to a common target. One embodiment includes polynucleotide probes having photoreactive functional groups. The probes are capable of assuming substantially contiguous reactive positions on a target polynucleotide placing the photoreactive groups in juxtaposition. Activation of the photoreactive functional groups with radiant energy form a probe reaction product in which the probes are bound to each other.
Patent AU-764467-B2 (AU)
Title: (3R,4R)-delta-tetrahydrocannabinol-11-OIC acids useful as antiinflammatory agents and analgesics
Inventor: BURSTEIN SUMNER H
IPC: A61K31/352
Filed: 1998-10-14
Granted: 2003-08-21
Abstract: The present invention relates to non-psychoactive derivatives of tetrahydro-cannabinol, which exhibit anti-inflammatory, analgesic and leukocyte antiadhesion activities. The invention includes novel derivatives of (3R,4R)-DELTA8-tetrahydrocannabinol-11-oic acids [hereinafter referred to as (3R,4R)-DELTA8-THC-11-oic acid], as well as pharmaceutical compositions containing the (3R,4R)-DELTA8-THC-11-oic acid derivatives. The invention further covers methods of administering the novel derivatives and pharmaceutical compositions as therapeutic agents in the treatment of pain and tissue inflammation. Non-psychoactive derivatives of DELTA8-THC-11-oic acid are described which have analgesic and anti-inflammatory properties.
Patent AU-592695-B2 (AU)
Title: A process for the removal of ethylene oxide and/or propylene oxide from surface-active derivatives
Inventor: FRIEDRICH KLAUS DR
IPC: C07C41/42
Filed: 1988-03-17
Granted: 1990-01-18
Abstract: 1. A process for the removal of ethylene oxide and/or propylene oxide and, optionally, dioxane from surface-active derivatives - prepared by ethoxylation and/or propoxylation - of organic compounds containing at least one active hydrogen atom, characterized in that the surface-active derivatives are treated with steam, optionally in vacuo, at temperatures of 70 to 130 degrees C and the steam treated product is optionally dried.
Patent AU-647253-B2 (AU)
Title: Process and reduction and melting furnace for producing liquid metal from fine metal oxide particles
Inventor: WEBER RALPH
IPC: C21B13/00
Filed: 1992-03-13
Granted: 1994-03-17
Abstract: In a process and an apparatus for the production of liquid metal (4) from fine-grain metal oxide particles, the particles, together with hot reducing gas, are blown against a heated bulk material filter layer (9) of lump coal and/or ceramic pieces, a substantial proportion of the particles being retained on and in the filter layer and subjected to finishing reducing by the reducing gas. A high-temperature flame is produced in front of the filter layer (9) by an oxygen-bearing gas being blown against the filter layer, and the metallised particles which are retained in the filter layer are melted. They pass in the liquid condition through the filter layer (9) into a receiving space (3) for liquid metal (4).
Patent AU-680112-B2 (AU)
Title: Controlled release hydrogel formulation
Inventor: CHEN CHIH-MING
IPC: A61K9/22
Filed: 1995-01-18
Granted: 1997-07-17
Abstract: The invention is directed to a method for the modification of the rate of release of a drug from a hydrogel which is based on the use of an effective amount of a pharmaceutically acceptable ionizable compound that is capable of providing a substantially zero-order release rate of drug from the hydrogel.
Patent AU-661021-B2 (AU)
Title: Capsule extrusion systems
Inventor: AEBISCHER PATRICK
IPC: C12N5/00
Filed: 1992-06-25
Granted: 1995-07-13
Abstract: Methods for producing cell capsules are disclosed in which a coagulant (22), which can include a cell suspension or other biologically active factor, and a polymeric casting solution (26) are extruded through a common extrusion port (14) having at least two concentric bores, such that the coagulant is extruded through the inner bore (16) and the polymeric casting solution is extruded through the outer bore (18). The method involves initiating extrusion of the coagulant within a temporal range of about 10 msecs to about one second from initiating delivery of the casting solution through the respective bores. Delivery of the coagulant is then shut off, and extrusion of the casting solution is terminated either immediately or after some predetermined time.
Patent AU-621559-B2 (AU)
Title: Piperidine-tetra hydrofurane or tetra hydrothiophene spiro derivatives and methods for their preparation
Inventor: TSUKAMOTO SHIN-ICHI
IPC: C07D211/48
Filed: 1988-10-05
Granted: 1992-03-19
Abstract: Heterocyclic spiro compounds of formula <CHEM> @ @C represents a piperidine ring of which the nitrogene atom may have substituent(s) selected from alkyl, alkanoyl and alkoxycarbonyl and/or may be connected to a ring carbon (other than the common carbon atom of the spiro structure) via an alkylene bridging group;  X represents an oxygen of sulfur atom;    Y represents a carbonyl group (- @-), a thiocarbonyl group (@@@),    a group of the formula @CH-R<5>, a group of the formula <CHEM>  or a group of the formula <CHEM>  wherein Alk is alkylene and Z<1> and Z<2> are the same or different and selected from oxygen and sulfur atoms; R<1>, R<2> and R<3> are the same of different and selected from a hydrogen atom and alkyl R<4> represents a hydrogen atom or alkyl, carboxy, alkoxycarbonyl, or alkanoyl group; R<5> represents a halogen atom or a hydroxyl, mercapto, alkoxy, alkylthio, alkanoyloxy, or alkanoylthio group; and R<6> and R<7> are the same of different and selected from a hydrogen atom and alkyl groups. The above compounds act upon muscarinic acetylcholine receptors, thereby activating the acetylcholine nervous functions in the central nervous system.
Patent AU-619768-B2 (AU)
Title: Polypeptides
Inventor: BALLANCE DAVID JAMES
IPC: C12N15/00
Filed: 1988-10-19
Granted: 1992-02-06
Abstract: Polypeptides corresponding to mature human serum albumin residues 1 to n, where n is between 369 and 419 inclusive, are useful as substitutes for albumin in the treatment of burns and shock in humans, the clearances of undesirable compounds, (such as bilirubin) from human blood, in laboratory growth media and in HSA assays. HSA (1-389) is particularly preferred, although not novel per se. The polypeptides may be produced by recombinant DNA techniques, especially in yeast.
Patent AU-567913-B2 (AU)
Title: Muscle building apparatus
Inventor: LANTZ INGVAR
IPC: A63B/
Filed: 1983-12-06
Granted: 1987-12-10
Abstract: PCT No. PCT/SE83/00430 Sec. 371 Date Aug. 23, 1984 Sec. 102(e) Date Aug. 23, 1984 PCT Filed Dec. 6, 1983 PCT Pub. No. WO84/02659 PCT Pub. Date Jul. 19, 1984.A muscle training apparatus comprising a force arm (1) which is rotatably mounted in a carrier (2) and which cooperates with a simple acting or double acting force applying means, especially a gas spring (8) which with one end is rotatably mounted in a bracket (7) of a lever arm (4) included in the force arm, and which with the opposite end is adapted for being mounted in an optional position in the carrier (2) on different distances from the axis of rotation (5) of said lever arm. The force arm (1) is adapted to quickly and easily be rotated from traction operation to pressure operation and vice versa and in an optional position on a support (3). Two or more force arms (1) can be mounted on one and the same support (3) for combined traction or pressure actuation in many different alternative embodiments.
Patent AU-691920-B2 (AU)
Title: Biphenyl Mannopyranoside Compounds
Inventor: KOGAN TIMOTHY P
IPC: C07H15/203
Filed: 1995-04-28
Granted: 1998-05-28
Abstract: This invention relates to compounds that inhibit the binding of E-selectin and/or P-selectin to sialyl-Lewisx or sialyl-Lewisa presented on a cell surface having the general structure    <IMAGE>   wherein X is selected from the group consisting of -(CH2)nCO2H, -O(CH2)mCO2H, -(CH2)nO(CH2)mCO2H, -CONH(CH2)mCO2H, -CH(OZ)(CO2H), -CH(Z)(CO2H), -(CH2)nSO3H, -(CH2)nPO3D1D2, -NH(CH2)mCO2H, -CONH(CHR6)CO2H, (1-H-tetrazolyl-5-alkyl-), and -OH; R1 and R2 are independently selected from the group consisting of hydrogen, alkyl, halogen, -OZ, -NO2, -NH2 and -NHZ; R3 is selected from the group consisting of hydrogen, halogen, alkyl, -OZ and -NHZ; R4 is selected from the group consisting of hydrogen, halogen, alkyl, hydroxyl, hydroxyl-O-sulfate and -OZ; R5 is selected from the group consisting of hydroxyl, -CN, -N3, -NH2, -NHNH2, -NE1E2, -NHE1, -NHCO(CH2)nCO2H, -S(CH2)mCO2H and -NHCHNHNH2; R6 is selected from the group consisting of hydrogen, alkyl, aralkyl, hydroxyalkyl, aminoalkyl, alkyl carboxylic acid and alkyl carboxamide; wherein n is 0 to 6, m is 1 to 6, p is 0 to 6, b is 0 to 2, Z is alkyl, aryl or aralkyl, D1 and D2 are independantly hydrogen or alkyl, E1 is alkyl or -(CH2)8CO2H, and E2 is alkyl, and the pharmaceutically acceptable salts, esters, amides, and prodrugs thereof. This invention also relates to methods of inhibiting the binding of E-selectin and/or P-selectin to sialyl-Lewisx or sialyl-Lewisa presented on a cell surface using said compounds and to pharmaceutically active compositions comprising compounds that inhibit the binding of E-selectin to sialyl-Lewisx and to methods of treatment of septic shock, ARDS, Crohn's disease, chronic inflammatory diseases, such as psoriasis and rheumatoid arthritis, and reperfusion injuries that occur following heart attacks, strokes and organ transplants.
Patent AU-655074-B2 (AU)
Title: Gasoline composition
Inventor: GRAIFF LEONARD BALDINE
IPC: C10L1/22
Filed: 1992-09-22
Granted: 1994-12-01
Abstract: The invention provides a gasoline composition comprising a major amount of a gasoline and from 5 ppmw to 1,000 ppmw based on the gasoline composition of a mixture of (a) an oil soluble polyamine selected from the group consisting of (i) a defined aliphatic alkylene polyamine, (ii) a defined Mannich polyamine, and (iii) mixtures of (i) and (ii); and (b) an oil soluble hydrocarbyl poly(oxyalkylene) aminocarbamate having a number average molecular weight in the range from 600 to 10,000 having at least one basic nitrogen atom wherein said hydrocarbyl group contains from 1 to 30 carbon atoms, and wherein the weight ratio of said polyamine (a) to said hydrocarbyl poly(oxyalkylene) aminocarbamate (b) ranges from 3:1 to 1:2; and a gasoline additive concentrate containing said mixture.
Patent AU-684369-B2 (AU)
Title: Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines
Inventor: COHEN IRUN R
IPC: A61K39/02
Filed: 1995-05-24
Granted: 1997-12-11
Abstract: The invention relates to conjugates of poorly immunogenic antigens, e.g., peptides, proteins and polysaccharides, with a synthetic peptide carrier constituting a T cell epitope derived from the sequence of E. coli hsp65 (GroEL), or an analog thereof, said peptide or analog being capable of increasing substantially the immunogenicity of the poorly immunogenic antigen. A suitable peptide according to the invention is Pep287e, which corresponds to positions 437-453 of the E. coli hsp65 molecule.
Patent AU-640090-B2 (AU)
Title: Storable protein solution
IPC: C12N9/96
Filed: 1992-10-12
Granted: 1993-08-12
Abstract: A storage-stable POD conjugate solution is characterised by a pH of 5.0 to 6.5 which is adjusted by an organic buffer substance in a concentration of 40 to 100 mmol/l and/or 0.05 to 1.0 mol/l magnesium aspartate.
Patent AU-610297-B2 (AU)
Title: Aryloxyphenylpropylamines and their preparation and use
Inventor: JAKOBSEN PALLE
IPC: C07D317/64
Filed: 1988-11-30
Granted: 1991-05-16
Abstract: Novel aryloxyphenylpropylamines having the formula <CHEM>  wherein R<1> is C3-7-cycloalkyl, C3-10-alkyl, or alkenyl which may be straight, branched or cyclic, unsubstituted or substituted with C1-4-alkoxy, aryloxy or cycloalkyl or cycloalkylalkyl; and R<2> is 3,4-methylenedioxyphenyl, aryl or heteroaryl, which are optionally substituted with one or more cyano, halogen, C1-6-alkyl, C1-6-alkoxy, C1-6-alkenyl, trifluoromethyl, C3-5-alkylene, aryloxy or aralkoxy  and a salt thereof with a pharmaceutically acceptable acid. The novel compounds are useful in the treatment of anoxia, migraine, ischemia and epilepsy.
Patent AU-658022-B2 (AU)
Title: Corrosion-resistant nail for driving into hard materials
Inventor: SARTOR DIETMAR
IPC: C22C38/38
Filed: 1992-11-16
Granted: 1995-03-30
Abstract: Nails are driven into hard receiving materials such as concrete, rock, metal and the like by explosive powder charge operated setting tools. To achieve the high mechanical strength required for such nails, the nails are formed of two parts, one a shank and the other a head fitted onto the shank. While the head is formed of a deformable corrosion resistant steel, the shank is formed of an austenitic steel alloyed with nitrogen having a very high mechanical strength. The steel forming the shank can only be shaped to a very limited extent, whereby a narrow flange is provided on the rear end of the shank. A disk fitted on the shank serves as a guide for the nails during the driving operation.
Patent AU-746012-B2 (AU)
Title: Microbicidal compositions and methods using synergistic combinations of propiconazole and 2-mercaptobenzothiazole
Inventor: PILLAY ALLAN
IPC: A01M29/12
Filed: 1999-03-05
Granted: 2002-04-11
Abstract: Microbicidal compositions containing synergistic combinations of propiconazole, (RS)- 1-2-[(2, 4-dichlorophenyl)-2- propyl-1,3-dioxanlan- 2ylmethyl]-1H-1,2, 4-triazole, and 2-mercaptobenzothiazole or alkali metal salt thereof are described. The propiconazole and 2-mercaptobenzothiazole or an alkali metal salt thereof are applied to a substrate or aqueous system subject to the growth of at least one microorganism. Methods for controlling the growth of microorganisms on various substrates and in various aqueous systems are also described. The combination of propiconazole and 2-mercaptobenzothiazole or an alkali metal salt thereof is particularly useful as microbicidal in the leather industry, the lumber industry, the papermaking industry, the textile industry, the agricultural industry, and the coating industry, as well as in industrial process waters.
Patent AU-567353-B2 (AU)
Title: Negative copy production using 1,2-quinone diazides
Inventor: STAHLHOFEN PAUL
IPC: G03F7/022
Filed: 1984-07-11
Granted: 1987-11-19
Abstract: A process for producing negative relief copies is disclosed in which a light-sensitive material, consisting essentially of (1) a binder which is insoluble in water and soluble in aqueous-alkaline solutions and (2) a light-sensitive ester or amide of a 1,2-benzoquinone-2-diazide-4-sulfonic acid, a 1,2-benzoquinone-2-diazide-4-carboxylic acid, a 1,2-naphthoquinone-2-diazide-4-sulfonic acid, or a 1,2-naphthoquinone-2-diazide-4-carboxylic acid, is imagewise exposed, thereafter heated and, after cooling, exposed again without an original, and subsequently developed by means of an aqueous-alkaline developer. The disclosed process permits the production of negative copies with the aid of a material which yields positive copies when it is processed in a conventional manner.
Patent AU-570501-B2 (AU)
Title: Pmc transcoders
Inventor: RABAEY DIRK HERMAN LUTGARDIS C
IPC: H03M7/50
Filed: 1984-09-13
Granted: 1988-03-17
Abstract: The present Pulse Code Modulation (PCM) translators include a first translator (COLI) for translating a PCM input word coded according to the A or mu-law into a linear PCM output word and a second translator (LICO) for translating a linear PCM input word into a PCM output word coded according to the A or mu-law. The choice of the A-law or mu-law is done by selecting the binary value of a single control bit (A).
Patent AU-699925-B2 (AU)
Title: Inner covering for the connecting corridors between rail vehicles
Inventor: MELZER NORBERT
IPC: B61D17/20
Filed: 1995-10-03
Granted: 1998-12-17
Abstract: PCT No. PCT/CH95/00222 Sec. 371 Date Aug. 2, 1996 Sec. 102(e) Date Aug. 2, 1996 PCT Filed Oct. 3, 1995 PCT Pub. No. WO96/10510 PCT Pub. Date Apr. 11, 1996The inner covering for the connecting corridors between cars of rail vehicles consists in each case of side wings, each of which consists of at least two independent frames (1, 2, 3) the spars of which are pivoted to each other at the corners, the frames being held in bottom and top telescopic guide rails (4). When the outermost vertical frame spars are fastened by hinges (8) to the car body or coupling frame, the inner covering can follow all movements which occur.
Patent AU-706640-B2 (AU)
Title: Cable splice closure
Inventor: WAMBEKE ALAIN
IPC: H02G15/007
Filed: 1995-09-19
Granted: 1999-06-17
Abstract: A cable gripper is disclosed, which comprises two or more strips and one or more connecting members extending between and interconnecting the strips. In use, the strips are wound around a cable to grip the cable, and each strip has the ability to decrease in length when wound and compressed around a cable, thereby allowing it to contract, and therefore tighten, around the cable. There may additionally be sealing material between the strips, for example in the form of a strip. <IMAGE>
Patent AU-741785-B2 (AU)
Title: Security element for electronic article surveillance and method of manufacturing a security element
Inventor: ALTWASSER RICHARD
IPC: G08B13/24
Filed: 1999-08-19
Granted: 2001-12-06
Abstract: The present invention relates to a security element for electronic article surveillance, having one lower and one upper conducting track with at least one winding each, the two conducting tracks being wound in opposing directions and overlapping in at least one area of overlap, and a dielectric layer in the area of overlap between the two conducting tracks. In a critical area in which a border edge of the lower and upper conducting tracks overlap, the dielectric layer is thicker than in the remaining area of overlap. The present invention also relates to a method of manufacturing such a security element.
Patent AU-746973-B2 (AU)
Title: Particulate acellular tissue matrix
Inventor: GRIFFEY EDWARD S
IPC: A61K35/36
Filed: 1999-06-18
Granted: 2002-05-09
Abstract: A method of processing an acellular tissue matrix to give a particulate acellular tissue matrix includes: cutting sheets of dry acellular tissue matrix into strips; cryofracturing the dry acellular tissue matrix strips at cryogenic temperatures; separating the resulting particles by size at cryogenic temperatures; and freeze drying the fraction of particles of desired size to remove any moisture that may have been absorbed to give a dry particulate acellular tissue matrix. Rehydration of the dry particulate acellular tissue matrix may take place just prior to use. The particulate acellular tissue may be applied to a recipient site, by way of injection, spraying, layering, packing, in-casing or combinations thereof. The particulate acellular tissue may further include growth and stimulating agents selected from epidermal growth factor, fibroblast growth factor, nerve growth factor, keratinocyte growth factor, platelet derived growth factor, vasoactive intestinal peptide, stem cell factor, bone morphogetic proteins, chondrocyte growth factor and combinations thereof. Other pharmaceutically active compounds may be combined with the rehydrated particulate material including: analgesic drugs; hemostatic drugs; antibiotic drugs; local anesthetics and the like to enhance the acceptance of the implanted particulate material. The particulate material product may also be combined with stem cells selected from mesenchymal stem cells, epidermal stem cells, cartilage stem cells, hematopoietic stem cells and combinations thereof.
Patent AU-638903-B2 (AU)
Title: Pulmonary administration of pharmaceutically active substances
IPC: A61K9/00
Filed: 1989-12-29
Granted: 1993-07-08
Abstract: Pulmonary administration of a pharmaceutically active substance useful for local or systemic action which comprises, liposomes containing an effective amount of a pharmaceutically active substance, and an amount of alveolar surfactant protein effective to enhance transport of the liposomes across a pulmonary surface.
Patent AU-583569-B2 (AU)
Title: Oxetanones
Inventor: BARBIER PIERRE
IPC: A61K31/335
Filed: 1985-12-16
Granted: 1989-05-04
Abstract: Oxetanones of formula (I) and their salts with weak acids are new: R1 and R2 = 1-17C alkyl (opt. having up to 8 double or triple bonds and opt. interrupted by an O or S atom which is not alpha to an unsatd. C atom), phenyl, benzyl or -C6H4-X-C6H5, all opt. ring-substd. by 1-3 1-6C alkyl, alkoxy or alkylthio; X = O, S or (CH2)m; m = 0-3; R3 = H or 1-3C alkyl or alkanoyl; R4 = H or 1-3C alkyl; R5 = H, Ar or Ar-(1-3C) alkyl or is 1-7C alkyl, opt. interrupted by Y and/or substd. by Z; or R4 and R5 together make a 4-6 membered satd. ring; Y = O, S, NR6, CONR6 or NR6.CO; Z = OR7, SR7, NR7R8, CONR7R8 or NR7.COR8; n = 0 or 1, and if 1 then R5 = H; Ar = phenyl, opt. substd. by up to 3 R9 or ORa; R6, R7, R8 and R9 = H or 1-3C alkyl. Where R3 = HCO and R5 = isobutyl, or R3 = MeCO and R5 = carbamoylethyl and also R2 = undecyl or 2,5-undecadienyl and R1 = n-hexyl, then R4 is not H. Also new are ethanol derivs. (III): when R1 = n -hexyl and R2 = undecyl or 2Z,5Z-undecadienyl, at least one asymmetric C atom in the ring or in beta-position to the ring has the R configuration. -
Patent AU-626390-B2 (AU)
Title: Method for silicon reduction with dimercaptosuccinic acid (dmsa)
Inventor: GONICK HARVEY CRAIG
IPC: A61P13/02
Filed: 1990-03-14
Granted: 1992-07-30
Abstract: Dimercaptosuccinic Acid (DMSA) may be used to reduce the level of silicon in blood and tissue thereby reducing blood pressure, improving kidney function, preventing or retarding the progression of chronic renal failure, treating the accumulation of silicon in advanced kidney disease, and/or preventing the onset or improving the current status of dementia and Alzheimer's Disease.
Patent AU-578508-B2 (AU)
Title: Kitchen utensil for cutting vegetables into strips
Inventor: BORNER ALFRED
IPC: A47J43/25
Filed: 1985-12-31
Granted: 1988-10-27
Abstract: 1. A kitchen utensil for cutting potatoes, more particularly half cooked potatoes, into strips, comprising a baseplate (2), on the top of which there are disposed two stop surfaces (3, 4) and, situated therebetween in the cutting direction, cutters (5, 6) which project heightwise above the stop surfaces (3, 4) and which are open towards the bottom of the baseplate, the said cutters being disposed in mutually offset transverse rows and having, on both sides in relation to the cutting direction (A), U-shaped cutting edges (10, 11) extending at a right angle to the cutting direction, characterised in that the undersides of the cutters extend from the cutting edge (10, 11) to the end (12) of the cutter substantially in the form of the inside surface of a right-angled pipe bend.